Literature DB >> 7169985

Hypercalciuria in the syndrome of inappropriate secretion of antidiuretic hormone.

G Decaux, Y Van Laethem, M Van Kuyck, J Mockel.   

Abstract

Mild hypocalcemia was observed in 6 out of 12 patients with SIADH associated hyponatremia, this was in fact related to low albumin levels resulting partly from body fluid dilution. In the 7 SIADH patients where it was measured, we observed an increased fractional calcium excretion (3.2 +/- 1.7%) as long as the patients were hyponatremic. This was corrected by water restriction (0.73 +/- 0.4%, p less than 0.01). We suggest that volume expansion was responsible for the increased calcium clearance, and not hyponatremia by itself, since in volume depletion hyponatremia, calcium clearance was within the normal range. Mild hypocalcemia and hypercalciuria is a common finding in SIADH-associated hyponatremia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7169985

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  5 in total

1.  Stones: Tolvaptan might prevent kidney stone formation.

Authors:  Emmanuel Letavernier; Michel Daudon
Journal:  Nat Rev Urol       Date:  2016-02-02       Impact factor: 14.432

2.  Syndrome of inappropriate anti-diuresis induces volume-dependent hypercalciuria.

Authors:  J Grellier; A Jaafar; A Martin; M El Alaoui; C Lebely; I Tack; M Vallet
Journal:  Osteoporos Int       Date:  2017-08-15       Impact factor: 4.507

3.  Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly.

Authors:  W Musch; G Decaux
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

4.  Vasopressin regulates renal calcium excretion in humans.

Authors:  Guillaume Hanouna; Jean-Philippe Haymann; Laurent Baud; Emmanuel Letavernier
Journal:  Physiol Rep       Date:  2015-11

5.  Hyponatremia and the risk of kidney stones: A matched case-control study in a large U.S. health system.

Authors:  Naoto Tominaga; Stephen J Fernandez; Mihriye Mete; Nawar M Shara; Joseph G Verbalis
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.